Newsletter | December 10, 2025

12.10.25 -- Royalties In Hybrid Licensing Agreements: Careful Drafting Is Critical

FEATURED ARTICLE

Royalties In Hybrid Licensing Agreements: Careful Drafting Is Critical

Pay close attention to contract language regarding royalties, including when and where patents expire, or pay the price, write experts at Faegre Drinker and Aurobindo Pharma USA.

INDUSTRY INSIGHTS

Your Benefits To Working With A Clinical Research Marketing Agency

Distinguish your clinical trial through partnering with a clinical research marketing agency to effectively attract and retain eligible participant with customized campaigns and digital marketing.

Four Challenges That Stall Advanced Therapy Development

Advanced therapy speed-to-market is often slowed by fragmented planning. Optimize preclinical strategy and manufacturing partnerships to enhance scalability, affordability, and development flexibility.

Community Connections: Leveraging Localized Patient Access In Clinical Trials

This roundtable brought together several experts to discuss how expanding community-based research can transform clinical trial recruitment and representation.

Partnering For Success In Oncolytic Virus Development

Learn how to navigate decision-making at critical steps and find solutions to key challenges in process development and scale-up to expedite oncolytic virus programs.

Nanoparticle Engineering Addresses The Challenge Of Poor Aqueous Solubility

As pharma companies aim to overcome development obstacles, it is important to incorporate GMP expertise alongside novel technologies that can enhance the properties of APIs and dosage forms.

Transforming Environmental Monitoring And Sample Management

Discover how applying an OpEx framework to environmental monitoring and sample management can optimize workflows, improve resource utilization, and deliver measurable annual cost savings.